Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) EBT Margin (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of EBT Margin data on record, last reported at 11.21% in Q3 2025.

  • For Q3 2025, EBT Margin fell 1372.0% year-over-year to 11.21%; the TTM value through Dec 2025 reached 2.87%, down 2954.0%, while the annual FY2024 figure was 26.66%, 157.0% down from the prior year.
  • EBT Margin reached 11.21% in Q3 2025 per AMPH's latest filing, up from 490.96% in the prior quarter.
  • Across five years, EBT Margin topped out at 38.83% in Q4 2022 and bottomed at 490.96% in Q1 2025.
  • Average EBT Margin over 5 years is 4.81%, with a median of 24.05% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 2950bps in 2021, then tumbled -51883bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 22.47% in 2021, then skyrocketed by 73bps to 38.83% in 2022, then fell by -25bps to 29.14% in 2023, then decreased by -9bps to 26.47% in 2024, then tumbled by -58bps to 11.21% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 11.21% in Q3 2025, 490.96% in Q1 2025, and 26.47% in Q4 2024.